Conditionally Reprogrammed Cells from Patient-Derived Xenograft to Model Neuroendocrine Prostate Cancer Development
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Conditionally Reprogrammed Cells from Patient-Derived Xenograft to Model Neuroendocrine Prostate Cancer Development
Authors
Keywords
-
Journal
Cells
Volume 9, Issue 6, Pages 1398
Publisher
MDPI AG
Online
2020-06-05
DOI
10.3390/cells9061398
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A synopsis of prostate organoid methodologies, applications, and limitations
- (2020) Anna M. Gleave et al. PROSTATE
- Lineage plasticity in cancer: a shared pathway of therapeutic resistance
- (2020) Álvaro Quintanal-Villalonga et al. Nature Reviews Clinical Oncology
- Cellular rewiring in lethal prostate cancer: the architect of drug resistance
- (2020) Marc Carceles-Cordon et al. Nature Reviews Urology
- ONECUT2 is a driver of neuroendocrine prostate cancer
- (2019) Haiyang Guo et al. Nature Communications
- Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells
- (2019) Takeshi Namekawa et al. Cells
- Genomic correlates of clinical outcome in advanced prostate cancer
- (2019) Wassim Abida et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The role of lineage plasticity in prostate cancer therapy resistance
- (2019) Himisha Beltran et al. CLINICAL CANCER RESEARCH
- Gene manipulation in liver ductal organoids by optimized recombinant adeno-associated virus vectors
- (2019) Jinsong Wei et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Morphologic Spectrum of Neuroendocrine Tumors of the Prostate: An Updated Review
- (2019) Jing Hu et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Clinical features of neuroendocrine prostate cancer
- (2019) Vincenza Conteduca et al. EUROPEAN JOURNAL OF CANCER
- Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks
- (2019) Palechor-Ceron et al. Cells
- Heterochromatin Protein 1α Mediates Development and Aggressiveness of Neuroendocrine Prostate Cancer
- (2018) Xinpei Ci et al. CANCER RESEARCH
- A PDX/Organoid Biobank of Advanced Prostate Cancers Captures Genomic and Phenotypic Heterogeneity for Disease Modeling and Therapeutic Screening
- (2018) Michael L. Beshiri et al. CLINICAL CANCER RESEARCH
- Expanding primary cells from mucoepidermoid and other salivary gland neoplasms for genetic and chemosensitivity testing
- (2018) Ahmad M. Alamri et al. Disease Models & Mechanisms
- Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study
- (2018) Rahul Aggarwal et al. JOURNAL OF CLINICAL ONCOLOGY
- Patient-derived conditionally reprogrammed cells maintain intra-tumor genetic heterogeneity
- (2018) Bruna R. S. Correa et al. Scientific Reports
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Maftools: efficient and comprehensive analysis of somatic variants in cancer
- (2018) Anand Mayakonda et al. GENOME RESEARCH
- Prostate Stem Cells and Cancer Stem Cells
- (2018) Jia J. Li et al. Cold Spring Harbor Perspectives in Medicine
- Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate Cancer
- (2017) Khalid Saeed et al. EUROPEAN UROLOGY
- SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition
- (2017) Yinan Li et al. EUROPEAN UROLOGY
- Generation of stable PDX derived cell lines using conditional reprogramming
- (2017) Alexandra Borodovsky et al. Molecular Cancer
- Conditional reprogramming and long-term expansion of normal and tumor cells from human biospecimens
- (2017) Xuefeng Liu et al. Nature Protocols
- SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer
- (2017) Ping Mu et al. SCIENCE
- A multiplex preclinical model for adenoid cystic carcinoma of the salivary gland identifies regorafenib as a potential therapeutic drug
- (2017) Chen Chen et al. Scientific Reports
- BBMerge – Accurate paired shotgun read merging via overlap
- (2017) Brian Bushnell et al. PLoS One
- Subrenal capsule grafting technology in human cancer modeling and translational cancer research
- (2016) Yuzhuo Wang et al. DIFFERENTIATION
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
- (2016) Himisha Beltran et al. NATURE MEDICINE
- The role of epigenetics and long noncoding RNA MIAT in neuroendocrine prostate cancer
- (2016) Francesco Crea et al. Epigenomics
- The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer
- (2016) Jennifer L. Bishop et al. Cancer Discovery
- Conditionally reprogrammed normal and primary tumor prostate epithelial cells: a novel patient-derived cell model for studies of human prostate cancer
- (2016) Olga A. Timofeeva et al. Oncotarget
- Developing in vitro models of human ductal carcinoma in situ from primary tissue explants
- (2015) Daniel D. Brown et al. BREAST CANCER RESEARCH AND TREATMENT
- KLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulation
- (2015) Xinpei Ci et al. Molecular Cancer
- The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer
- (2015) Shusuke Akamatsu et al. Cell Reports
- Polycomb-mediated silencing in neuroendocrine prostate cancer
- (2015) Pier-Luc Clermont et al. Clinical Epigenetics
- Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer
- (2015) Dong Lin et al. Oncotarget
- Organoid Cultures Derived from Patients with Advanced Prostate Cancer
- (2014) Dong Gao et al. CELL
- High Fidelity Patient-Derived Xenografts for Accelerating Prostate Cancer Discovery and Drug Development
- (2013) D. Lin et al. CANCER RESEARCH
- Of mice and men-warning: Intact versus castrated adult male mice as xenograft hosts are equivalent to hypogonadal versus abiraterone treated aging human males, respectively
- (2013) J.P. Michiel Sedelaar et al. PROSTATE
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- Conditionally reprogrammed cells represent a stem-like state of adult epithelial cells
- (2012) F. A. Suprynowicz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ROCK Inhibitor and Feeder Cells Induce the Conditional Reprogramming of Epithelial Cells
- (2011) Xuefeng Liu et al. AMERICAN JOURNAL OF PATHOLOGY
- The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
- (2010) A. McKenna et al. GENOME RESEARCH
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
- (2010) K. Wang et al. NUCLEIC ACIDS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More